EyePoint Pharmaceuticals, Inc. Share Agreements

4 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to Share Purchase Agreement, dated February 1, 2021, by and between EyePoint Pharmaceuticals, Inc. and Ocumension Therapeutics
Share Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
DE
2021
Share Purchase Agreement, dated December 31, 2020, by and between EyePoint Pharmaceuticals, Inc. and Ocumension Therapeutics
Share Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
DE
2021
PSIVIDA CORP. CommonStock (par value $0.001 per share) At Market Issuance Sales Agreement
Share Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
NJ
2017
PSIVIDA CORP. CommonStock (par value $0.001 per share) At Market Issuance Sales Agreement
Share Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
NY
2013